• Users Online: 48
  • Print this page
  • Email this page
REVIEW FOR THE SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES
Year : 2014  |  Volume : 7  |  Issue : 3  |  Page : 343-353

Progress in vaccination


Paediatrics Department, University of Pennsylvania, Philadelphia, PA, USA

Correspondence Address:
Stanley A Plotkin
Paediatrics Department, University of Pennsylvania, Philadelphia, PA
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7707/hmj.348

Rights and Permissions

During the lifetime of the author, vaccination has evolved in the complexity of its targets and the technologies used to overcome that complexity. This point is illustrated using the development of several vaccines. Rubella was, and in some countries still is, a major cause of birth defects when infection occurs during pregnancy. In order to prevent infection by a wild virus, a strain was isolated from a congenital infection and attenuated by passage in human fibroblasts at low temperature. The resultant virus was attenuated and could immunize mothers and thus prevent congenital infection and abnormalities. Although rabies vaccines had been developed in the nineteenth century, the available vaccines were poorly immunogenic and sometimes failed to protect. The virus was adapted to cell culture and inactivated with beta-propiolactone. This resulted in highly immunogenic vaccines that can protect after three or four doses only. Infantile gastroenteritis is a problem throughout the world and its major cause is the rotaviruses. In order to prevent infection, a bovine rotavirus was combined with antigens from human strains by the technique of reassortment of segmented RNA. The resulting vaccine was attenuated but could infect infants and generate protective responses at the intestinal level. Finally, cytomegalovirus is now the number one infectious cause of congenital abnormalities. To prevent this virus from infecting pregnant women, a variety of approaches are being taken to develop a vaccine, including using glycoproteins from the virus, developing vaccine replication-defective strains and DNA plasmids.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed204    
    Printed13    
    Emailed0    
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal